Analysis of Anti-infective Treatment and Monitoring of Adverse Reactions in a Case of Pulmonary Infection with Multidrug Resistant Acinetobacter Baumannii

Han Fang, Zhe Wang

Abstract


Objective: To discuss the characteristics of anti-infection treatment of multidrug-resistant acinetobacter baumannii in pulmonary infection and the necessity of pharmaceutical care. Methods: Taking a case of pneumonia with multidrug-resistant acinetobacter baumannii indicated by pulmonary alveolar lavage fluid as an example, which was treated by clinical pharmacists in the form of consultation. And expounding the importance of rational use of antibiotics and characteristics of pharmaceutical care by referring to literature and pharmacokinetics. Results: Multidrug-resistant acinetobacter baumannii was found by alveolar lavage after admission, and the infection symptoms were not effectively controlled after tigecycline treatment.With the consultation assistance of clinical pharmacists, it was found that the patient had low albumin, which had a great influence on tigecycline with high protein binding rate. Later, cefoperazone sulbactam + tigecycline was used on the premise of albumin supplementation. That is recommended by clinical pharmacists.One week later, the patient’s symptoms improved and were discharged. During the treatment, the clinical pharmacist took pharmaceutical care of the patient, timely solved the adverse reaction of vomiting in the early stage of medication, and solved the concerns of doctors. Conclusions: In the case of pulmonary infection with multidrug-resistant Acinetobacter baumannii, not only the drug sensitivity list, we should also refer to the pharmacokinetics of drugs and monitor the adverse reactions of drugs in the process of treatment, which has a certain positive significance for the scientific use of antibiotics.

Keywords


Acinetobacter baumannii; Antiinfective therapy; Clinical pharmacist; Pharmacokinetics

References


Infectious group, respiratory branch, Chinese Medical Association.

Guidelines for the diagnosis and treatment of hospital acquired

pneumonia and ventilator-associated pneumonia in Chinese adult

hospitals (2018 Edition)[J]. Chinese Journal of tuberculosis and

respiration, 2018, 41 (4): 255-280.

World Health Organization. “Guidelines for the Prevention and

Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter

baumannii and Pseudomonas aeruginosa in Health Care

Facilities.” (2017).

Peleg A Y, Seifert H, Paterson D L. Acinetobacter baumannii:

emergence of a successful pathogen.[J]. Clinical Microbiology Reviews,

, 21(3):538-582.

Nikolich-Ugich J. The twilight of immunity: emerging concepts

in aging of the immune system[J]. Nature Immunology, 2017,

(1):10-19.

Henig O, Kaye K S. Bacterial Pneumonia in Older Adults[J]. Infect

Dis Clin North Am, 2017:págs. 689-713.

Benson, and M. John. “Antimicrobial Pharmacokinetics and Pharmacodynamics

in Older Adults.” Infectious Disease Clinics of

North America 31.4(2017):609.

Chen Baiyi, he Lixian, Hu Bijie, et al. Consensus of Chinese ex-perts on diagnosis, treatment and prevention of Acinetobacter baumannii

infection[J]. Chinese medical science, 2012.

Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation

of innate immunity. Nat Rev Immunol.2013;13:875-887.

Chakhtoura N E, Bonomo R A, Jump R . Influence of Aging and

Environment on Presentation of Infection in Older Adults[J]. Infectious

Disease Clinics of North America, 2017, 31(4):593-608.

Song Ge. Application of bronchoalveolar lavage in the treatment

of respiratory critical illness[C] /academic conference of

critical illness medical professional committee of Shandong

pathophysiology society. Critical illness medical professional

committee of Shandong pathophysiology society; Emergency

medical doctors branch of Shandong Medical Association, 2013.

Patel, I S. Relationship between bacterial colonisation and the

frequency, character, and severity of COPD exacerbations[J].

Thorax, 2002, 57(9):759.

Respiratory branch of Chinese Medical Association. Guidelines

for the diagnosis and treatment of community-acquired pneumonia

in Chinese adults (2016 Edition)[J]. Chinese Journal of tuberculosis

and respiration, 2016,39 (4): 253-279.

Higgins P G, Wisplinghoff H, Krut O, et al. A PCR-based method

to differentiate between Acinetobacter baumannii and Acinetobacter

genomic species 13TU[J]. Clinical Microbiology and

Infection, 2007, 13.

Chen Daijie, Guo Beining, Yang Xinyi, et al. Drug resistance

mechanism of Acinetobacter baumannii[J]. Chinese Journal of

infection and chemotherapy, 2015 (3).

Roberts J A, Lipman J. Pharmacokinetic issues for antibiotics

in the critically ill patient.[J]. Critical Care Medicine, 2009,

(3):840.

Professional Committee of infectious diseases of China Medical

Education Association. Expert consensus on clinical application

of antimicrobial pharmacokinetic / pharmacodynamic theory[J].

Chinese Journal of tuberculosis and respiration, 2018,41 (6):

-446.

Chen Jing Jing, Qian Peipei, Cao Kai, et al. Comparison and

analysis of adverse drug reaction correlation evaluation method

and Noel’s evaluation scale method in China[J]. China Pharmaceutical

, Vol. 34, No. 8, pp. 988-992, istic Ca, 2020.

Joel g. Hardman, Lee E. limbird, Jin Youyu. Pharmacological

basis of Goodman Gilman therapeutics[J]. People’s Health Publishing

House, 2004.

Cui Hongxia, Yu Suwen. Retrospective analysis of 125 cases of

adverse reactions of tegacyclin[J]. China pharmacovigilance,

, v.15; No.140(08):45-48.

Yu Wen, Sui Jie, Li Chengjian. Literature review of adverse reactions

of tegacyclin[J]. Chinese Journal of drug abuse prevention

and control, 2018, 024 (001): 45-46.




DOI: https://doi.org/10.12346/jnp.v1i1.4253

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Han Fang, Zhe Wang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.